Nwk Group, Inc. Grifols Sa Transaction History
Nwk Group, Inc.
- $213 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding GRFS
# of Institutions
150Shares Held
140MCall Options Held
3.54MPut Options Held
919K-
Capital World Investors Los Angeles, CA20.7MShares$175 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA17.1MShares$144 Million1.53% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny14.4MShares$121 Million0.04% of portfolio
-
Permian Investment Partners, LP New York, NY12.8MShares$108 Million11.07% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.5MShares$96.4 Million2.32% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.71B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...